It may not look like it on the basis of the last few quarters, but Agilent (NYSE: A ) is getting better. Weakness in multiple test and mea...
It may not look like it on the basis of the last few quarters, but Agilent (NYSE: A ) is getting better. Weakness in multiple test and mea...
It's getting harder for me not to view Agilent (NYSE: A ) as something like the store-brand version of Danaher (NYSE: DHR ). It's...